Tamara van Gorkom

Tamara van Gorkom

Auto-generated profile, based on publicly available information

Tamara van Gorkom

Department of Medical Microbiology and Immunology, Diakonessenhuis Hospital, Utrecht, the Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
DHDieneke Hoeve-Bakker
Dieneke Hoeve-Bakker
MJMark Jonker
Mark Jonker
ABAfke H. Brandenburg
Afke H. Brandenburg
PRP. Martijn Den Reijer
P. Martijn Den Reijer
FSFoekje F. Stelma
Foekje F. Stelma
KKKristin Kremer
Kristin Kremer
Serology plays an important role in the diagnosis of Lyme borreliosis. Guidelines prescribe a two-tier testing algorithm in which a highly sensitive screening assay is used for screening and reactive sera are retested with an immunoblot to reduce false positivity rates.

18 August 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
TGTamara van Gorkom
Tamara van Gorkom
GAGijs H. J. van Arkel
Gijs H. J. van Arkel
MHMichiel Heron
Michiel Heron
WVWillem Voet
Willem Voet
STSteven F. T. Thijsen
Steven F. T. Thijsen
KKKristin Kremer
Kristin Kremer
Recent studies have shown elevated levels of the B-cell chemokine (C-X-C motif) ligand 13 (CXCL13) in the cerebrospinal fluid (CSF) of patients with early Lyme neuroborreliosis (LNB). In this retrospective study, we evaluated the diagnostic performance of the Quantikine CXCL13 enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Inc., MN, USA) and the recom Bead CXCL13 assay (Mikrogen, Neuried, Germany) for the detection of CXCL13 in CSF.

26 July 2017 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
TGT. van Gorkom
T. van Gorkom
KKK. Kremer
K. Kremer
WVW. Voet
W. Voet
DND. W. Notermans
D. W. Notermans
BVB. J. M. Vlaminckx
B. J. M. Vlaminckx
STS. F. T. Thijsen
S. F. T. Thijsen
The diagnosis of Lyme borreliosis is challenging because of the often non-specific symptoms and persisting antibodies after infection. We investigated the diagnostic characteristics of two enzyme-linked immunosorbent assays (ELISAs) and an immunoblot for the detection of Borrelia-specific serum antibodies using different test strategies in individuals with and without antibiotic treatment for Lyme borreliosis. This retrospective study included healthy individuals, patients with active Lyme neuroborreliosis and patients treated for Lyme neuroborreliosis. Two ELISAs were compared: the C6 ELISA and the SERION ELISA. Equivocal and positive results were confirmed by immunoblot. We included 174 healthy individuals, of whom 27 (15.5%) were treated for Lyme borreliosis in the past, 36 patients were treated for Lyme neuroborreliosis and 27 patients had active Lyme neuroborreliosis. All the active Lyme neuroborreliosis patients were reactive in both ELISAs (100% sensitivity); less reactivity was seen in the other three groups (range 17.7% to 69.4%). The concordance between the ELISA results was high in active Lyme neuroborreliosis patients (26/27; 96.3%) and healthy individuals (131/147; 89.1%), but lower in treated healthy individuals (18/27; 66.7%) and treated Lyme neuroborreliosis patients (18/36; 50.0%) (p ≤ 0.005). This study showed that antibiotic treatment against Lyme borreliosis was strongly associated with discordant ELISA and test strategy results (odds ratio: 10.52; p < 0.001 and 9.98; p = 0.014, respectively) suggesting antibiotic treatment influences the pace at which the various antibodies directed to the different antigens used in both ELISAs wane. Among treated neuroborreliosis patients, the SERION ELISA stayed positive for a longer period after infection compared to the C6 ELISA. This should be taken into consideration when requesting and/or interpreting Lyme serology.

7 October 2024 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
DHDieneke Hoeve-Bakker
Dieneke Hoeve-Bakker
KKKaren Kerkhof
Karen Kerkhof
MHM. Heron
M. Heron
STS. F. T. Thijsen
S. F. T. Thijsen
TGT. van Gorkom
T. van Gorkom
Background Diagnosis of Lyme borreliosis (LB) relies on clinical symptoms and detection of Borrelia-specific antibodies. Guidelines recommend a two-tier testing (TTT) strategy for disseminated LB: serological screening with a sensitive enzyme immunoassay (EIA) and confirmation with a specific immunoblot. Searching for the most sensitive and specific approach, this retrospective study evaluated standard (STTT) and modified (MTTT) strategies using a well-defined study population. Methods Cases included patients with active Lyme neuroborreliosis (LNB; n = 29) or Lyme arthritis (LA; n = 17). Controls comprised patients treated for LNB (n = 36) or LA (n = 8), healthy individuals who were either untreated (n = 75) or treated for LB (n = 15) in the past, and patients with potentially cross-reactive diseases (n = 16). Sera were subjected to three EIAs and two immunoblots. Reactive screening results were confirmed by immunoblot (STTT) or EIA (MTTT). Solitary IgM results in the screening assay and effects of antibiotic treatment on isotype-specific seropositivity rates were also assessed. Results Sensitivities of STTT strategies ranged from 90%–97% for LNB and were 100% for LA. MTTT strategies were 100% sensitive. Specificities ranged from 89%–95% for STTT and from 88%–93% for MTTT strategies. Differences between STTT and MTTT strategies were not statistically significant. Solitary IgM reactivity was common among controls. Antibiotic treatment significantly reduced IgM/IgG positivity for LNB patients; for LA patients, a decline was only observed for IgM. Conclusion In conclusion, MTTT strategies showed a slightly higher sensitivity and similar specificity compared to STTT strategies. Since EIAs are more time- and cost-efficient, MTTT strategies seem more favorable for clinical use. IgG testing enhances specificity with minimal sensitivity loss.

29 June 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
TGTamara van Gorkom
Tamara van Gorkom
WVWillem Voet
Willem Voet
GAGijs H. J. van Arkel
Gijs H. J. van Arkel
MHMichiel Heron
Michiel Heron
DHDieneke Hoeve-Bakker
Dieneke Hoeve-Bakker
KKKristin Kremer
Kristin Kremer
The diagnosis of LNB is established by clinical symptoms, pleocytosis, and proof of intrathecal synthesis of Borrelia -specific antibodies. Laboratory diagnosis of LNB is challenging, and validated diagnostic algorithms are lacking.

19 July 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
TGTamara van Gorkom
Tamara van Gorkom
GAGijs H. J. van Arkel
Gijs H. J. van Arkel
WVWillem Voet
Willem Voet
STSteven F. T. Thijsen
Steven F. T. Thijsen
KKKristin Kremer
Kristin Kremer
The diagnosis of Lyme neuroborreliosis (LNB) is based on neurological symptoms, cerebrospinal fluid (CSF) pleocytosis, and intrathecally produced Borrelia -specific antibodies. In most cases, the presence of intrathecally produced Borrelia -specific antibodies is determined by using an enzyme-linked immunosorbent assay (ELISA).